MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix: Reports, Publications & Metrics
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Research Triangle, North Carolina
*Bioscience Regional Clusters & HotSpots
*Industry: Maryland (Medical & Health Information Technology, Biomedical, Biopharmaceutical & Biotechnology Sectors)
Precigen, Inc. (NASDAQ:PGEN), formerly, INIntrexon Corporation (NYSE: XON)*
Organization & Developments: Intrexon
Parents
Precigen, Inc. (NASDAQ:PGEN), formerly, INIntrexon Corporation (NYSE: XON)*
Children
*Development of transcriptional therapeutics for critical human diseases,
*Mission is to redefine the product development cycle, reducing the time, cost, and technical risks inherent in engineering biological and cellular systems.
*Money directed to UltraVector platform used to design and construct complex transgenes to achieve qualities not found in nature.
*Over 400 patents and patent applications
*Synthetic biology company
*We are dedicated to realizing the exceptional advantages of Better DNA™
*Working on better protein-based drugs, gene therapy, industrial enzymes, and ag-biotech
2011: Halozyme Therapeutics, Inc. and Intrexon Corporation Licensing Deal Valued at $63 Million (2011)
2016: 3 Things Needed to Make Intrexon's Zika Virus Cure a Success
2016: FDA says engineered anti-Zika mosquito environmentally safe (March 11)
2016: Intrexon: The Public Markets' Theranos Part 1 - Zika Virus Hype Is Nonsensical - Intrexon Corp (NYSE:XON)
2019: Intrexon - The Opportunity Of A Lifetime - The Energy Assets_seekingalpha.com
2020: Biotech billionaire spends $88M to reorganize his long-suffering bioengineering businesses, hands off CEO role – Endpoints News
2021: Precigen UltraCAR-T Technology Flexes its Muscles at ASH Meeting
2024: Precigen: RRP Targeting With AdenoVerse Technology Platform_ seekingalpha.com
2025: Precigen: August Is Pivotal For This Biotech Innovator
2025: Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement
2025: Precigen's SWOT analysis: biotech firm's stock poised for growth with PRGN-2012
Jumps
*Key People: Intrexon
Finance & Acquisition: Intrexon